Mode
Text Size
Log in / Sign up
N/A N=30 Other

CoolSculpting the Upper Arm Study

Body Fat Disorder

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcome: Primary: Percentage of Pre-treatment Images Correctly Identified — 85.2 percent correctly identified images

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
CoolSculpting device with vacuum applicator. (Device)
Age
Adult, Older Adult · 22+ yrs
Sex
All
Sponsor
Zeltiq Aesthetics
Primary completion
Jun 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Pre-treatment Images Correctly Identified
85.2
PRIMARY
Safety of the CoolSculpting Device in Upper Arm Treatments

Summary

Evaluate the safety and efficacy of the ZELTIQ CoolSculpting System using a specialized surface applicator for non-invasive subcutaneous fat reduction in the upper arm.

Eligibility Criteria

Inclusion Criteria

  • Male or female subjects > 22 years of age and < 65 years of age.
  • Subject has clearly visible fat sufficient for treatment on the upper arm, which in the investigator's opinion, may benefit from the treatment.
  • No weight change exceeding 5% in the preceding month.
  • Subject agrees to maintain his/her weight (i.e., within 5% of total body weight) by not making any major changes in their diet or exercise routine during the course of the study.
  • Subject has read and signed the study written informed consent form.

Exclusion Criteria

  • History of a fat reduction procedure (e.g., liposuction, surgery, lipolytic agents, etc.), or implants in or adjacent to the area of intended treatment.
  • History of prior surgery in the arms.
  • Known history of cryoglobulinemia, cold urticaria, cold agglutinin disease, or paroxysmal cold hemoglobinuria.
  • Known history of Raynaud's disease, or any known condition with a response to cold exposure that limits blood flow to the skin.
  • History of bleeding disorder or is taking any medication that in the investigator's opinion may increase the subject's risk of bruising.
  • History of carpal tunnel syndrome, compartment syndrome or deep vein thrombosis in the upper extremities.
  • Currently taking or has taken diet pills or weight control supplements within the past month.
  • Any dermatological conditions, such as scars, infection, in the location of the treatment area that may interfere with the treatment or evaluation.
  • Active implanted device such as a pacemaker, defibrillator, or drug delivery system.
  • Pregnant or intending to become pregnant in the next 5 months.
  • Lactating or has been lactating in the past 6 months.
  • Unable or unwilling to comply with the study requirements.
  • Currently enrolled in a clinical study of any other unapproved investigational drug or device. Any other condition or laboratory value that would, in the professional opinion of the investigator, potentially affect the subject's response or the integrity of the data or would pose an unacceptable risk to the subject.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02669329). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search